Lagardere SCA (MMB)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 18.02 |
|---|---|
| 52-week range | 16.96 – 20.40 |
| Return, 1 month / 3 months | +0.1% / +2.0% |
| Return, 1 year / 3 years | −2.7% / +7.3% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 19.1% |
| Worst drawdown (1 year) | -13.2% |
| Average daily value traded | 0.22M EUR |
| Dividend yield | 3.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lagardere is a French media and publishing group based in Paris. Through Hachette Livre it publishes books and educational materials for readers and schools in many countries, and its travel retail arm runs shops and food outlets in airports, railway stations and other travel locations. The group also has interests in media and entertainment businesses, including publishing and broadcasting activities, serving consumers and business partners in France and internationally.
Lagardere SCA trades under the code MMB on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lagardere SCA (MMB) trades on the Euronext Paris in France. It last closed at EUR 18.02 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 51 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.7% and over the last three months it rose 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 74 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -1.4% | ||
| From 52-week high | -11.5% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.0% | ||
| 6-month return | 0.9% | ||
| 12-month return, skipping the last month | -2.8% | ||
| Stability (higher is calmer) | 93 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.2% | ||
| Liquidity | 70 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.22M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.7% |
|---|---|
| 1 month | +0.1% |
| 3 months | +2.0% |
| 6 months | +0.9% |
| 1 year | −2.7% |
| 3 years | +7.3% |
| 5 years | −4.9% |
Signals
| 50-day / 200-day average | 18.32 / 18.28 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.32 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 May 2026 | EUR 0.6700 |
| 30 Apr 2025 | EUR 0.6700 |
| 26 Apr 2024 | EUR 0.6500 |
| 19 Apr 2023 | EUR 1.3000 |
| 25 Apr 2022 | EUR 0.5000 |
| 14 May 2019 | EUR 1.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.